pHOSPHATE Salts

Contentus

• Et effective ...
• Verisimile est effective ...
• Potest enim effective ...
• Effectiveness rate ut quod est insufficiens ...
• & Cautiones admonitio specialis;

PHOSPHATE refers multis salibus ac diversis combinationibus ad eget ad PHOSPHATE et mineralibus sales. PHOSPHATE dairy cibis princeps in includit amet, totum frumentum cereals, nuces et certos cibos præscribunt. In cibo phosphates lacticiniis videtur inveniri absque phosphates corporibus facile absorberi grana. COLA bibit continent multum PHOSPHATE - adeo quidem, ut etiam quantum possunt facere PHOSPHATE in sanguinem.

PHOSPHATE populus salibus uti medicina est. Ne confundas phosphate organophosphates ut diximus substantiis quae venenosa.

PHOSPHATE sunt salibus plerumque adsuesco assuesco pro viscus purgatio, low sanguis campester of PHOSPHATE, constipation, altum sanguis campester of calcium et eructationibus.

Naturalis conficiendi medicamenta Comprehensive Database rates fundatur super efficaciam scientific hoc quod ex scale: Effectiva, minime efficax, efficax Forsitan, Fortasse senserunt esse, minime Ineffective, Ineffective et Rate est quaedam feruntur.

Et efficaciam ratings PHOSPHATE salium ita se habet:

Et effective ...

• Praeparans pro medical procedendi in alvum. Sodium phosphate ab ore Sumens products ante dictum est effective a colonoscopy pro purgatione alvum. Quidam products sodium phosphate (OsmoPrep, Salix Pharma: Visicol, Salix Pharma) probatus sunt per US Cibus et medicamentis Administration (FDA) quia hoc significatur. Sed taking sodium phosphate augeri periculo renibus damnum in aliqua populo. Propter quod, sodium phosphate products iam non sunt plerumque in in US in alvum præparátio ejus.
• Low campester in sanguine phosphate. Potassium sodium phosphate ab ore Sumens vel prohibendo vel ageretur est effective per PHOSPHATE low campester in sanguine. Intravenous PHOSPHATE diximus, ut PHOSPHATE et tractare low campester in sanguine quod sub auspicio usus medicus.

Verisimile est effective ...

• constipation. Sodium phosphate, est FDA-super-the-occurro licet (otc) ingrediens est curatio constipation. Haec products capta sunt ab oris seu ut usus enemas.
• cRUDITAS. PHOSPHATE et calcium aluminium sunt FDA-licet in rebus antacids.
• Princeps calcium in sanguine levels. Subterraneis elicantes Unguibus PHOSPHATE sal (nisi calcium) probabile est per os movent pro somes excelsum campester of calcium in sanguinem. Sed PHOSPHATE intravenous diximus esse non debet.

Potest enim effective ...

• Renibus lapides (nephrolithiasis). Kalium, calcium PHOSPHATE ab ore Sumens potest auxilium ne renibus lapides de formatam in aegris cum urina alta campester of calcium.

Effectiveness rate ut quod est insufficiens ...

• Curabitur aliquet euismod. Quidam research ostendit quod mane acceptis ab ore sodium phosphate in conspectu summus intensionem diebus VI sprinting aut cycling can amplio athletice effectus. Et primo investigationes ostendit nullum aliud bonum. More studiis necessaria sunt in coetibus populi maius est videre sodium phosphate est vere utilis. Ut diximus alias Accipiens calcium PHOSPHATE vel kalium currit et cycling PHOSPHATE non amplio perficientur.
• Complicationibus diabetes (diabetic ketoacidosis). Investigationis ostendit quod mane dare kalium intravenously PHOSPHATE (a VI), non autem meliorem diabete corpus producit nimis complicata, in quibus cum multae venae discurrant ketones acida vocatur. Homines hac conditione, si modo data cum phosphates si habet low campester PHOSPHATE.
• Osteogenesis imperfecta. Research ostendit quod si accipiatur adjuvat per os calcium amplio os densitatem in mulieribus, et spina minus coxae et Osteoporosis. Sed non opus magis quam alius fontes calcium, talis ut calcium carbonate.
• Complicationes praesertim ad id fieri comedere qui antea in populum fame pereo (refeeding syndrome). Research ostendit ut det mane et potassium sodium phosphate intravenously (per II) nutritionem per XXIV horas praeveniens refeeding syndrome quod restarting in fame eorum qui sunt graviter vel malnourished.
• sensitivo circa dentes meos.
• aliis conditionibus.

Quod necesse est ut plures PHOSPHATE rate diximus ad illos usus.

Avocatus cibo solent phosphates momenti oeconomiae corporis. Et infandae cupiditatis involvunt per structuram cell, industria navem onerariam et repono, munus Vitaminum et numerosis aliis processibus requiritur ad salutem. Phosphate salium possint alvum duci causando in tenuem intestini quippiam agere de contentis citius excitare.

Sodium sales quibus PHOSPHATE, kalium, aluminium, calcium sunt aut CREDIBILIS ARMARIUM pro quo capta est per os omnium hominum demissis in posteriore atque ima corporis, seu dedit intravenously (a VI), et appropriately brevis-term. Ut modo diximus esse intravenously Phosphate (a VI), per visum a medicus.

PHOSPHATE salium (expressit in iis phosphoris) sunt POTEST FIERI PERICULOSUS cum bibitur altior quam sumptus in IV P. * per diem pro adultis magis quam LXX annis iunior et qui senior populus ad III P. per die.

Diu terminus usus, potest ordinarius hospes molestus supervenit phosphates et chemicals in statera in corpus et debet viverra a curis professionales ad vitare gravis latus effectus. Potest irritare stomachum digestive tractus salium phosphate causam turbare ventris constipationem capitis languor aliisque quaestiones.

Sicut non confundimus phosphate salium organophosphates substantiis aut Tribasic potassium sodium phosphates Tribasic phosphates et quae venenosa.

& Cautiones admonitio specialis;

Graviditate ac loricam pascens: PHOSPHATE diximus de puritate alimentorum sunt fontes CREDIBILIS ARMARIUM pectus pascens vel gravida feminarum MCCL medicamentum ex quotidiano usu Suspendisse praebitis inter 14-18 annos matribus et per XVIII annorum DCC mg eos quotidie. Aliae sunt amounts POTEST FIERI PERICULOSUS modo adhiberi debent, et a curis professionales cum consilium cura et ongoing.

liberi: PHOSPHATE salia CREDIBILIS ARMARIUM Suspendisse at libero diurne sumpto ex formula CDLX filii 1-3 annorum; D mg 4-8 annis filii, et MCCL mg filii 9-18 annis. PHOSPHATE salia POTEST FIERI PERICULOSUS Si pecuniam consumi phosphate (phosphoris exprimitur) tolerabiliora superius attractio gradu superet (Ul). ULs sunt in III P. per die ad 1-8 annorum filii: IV P. * per diem et per IX annos senior infantes.

Morbus cordis: Fuge ab ea uti diximus continent sodium phosphate si cor morbo.

Liquor retention (OEDEMA): Fuge ab ea uti diximus continent sodium phosphate si CIRRHOSIS, cor defectum, OEDEMA, aut aliorum condiciones, quae potest facere.

Excelsum campester of calcium in sanguinem (hypercalcemia): Salum prudenter usus PHOSPHATE si hypercalcemia. Nimium calcium phosphate posset poni ubi non sit corpus.

Princeps gradus in sanguine phosphate: Acta cum Populi scriptor morbo, gravi cor et pulmonis morbo, renibus morbo, thyroid problems, et aliis iecoris morbo, qui plus quam verisimile ut develop nimis PHOSPHATE in sanguine ut PHOSPHATE ubi sales. Usus consilio permanenti modo diximus phosphate curis cura professionalem si ex istis.

ren morbus: Usus salium solum PHOSPHATE et permanentis cura consilium a curis professionales si ren problems.

moderatus

Videte, hoc compositum.

Bisphosphonates

Bisphosphonate sal salis can rememdium et PHOSPHATE et calcium inferioribus campester in corpore. Inito cum salibus bisphosphonate medicamenta magnum faciat calcium phosphate preme ut elit.

Quidam bisphosphonates includit alendronate (Fosamax), etidronate (Didronel), risedronate (Actonel), tiludronate (Skelid), et aliis.

Calcium;

Cum calcium PHOSPHATE cohaerere. Hoc reducit corporis viribus et calcium phosphate cogit. Hoc ne cuiusque II horis ante PHOSPHATE vel erit vel saltem post accipiens calcium.

ferrum

PHOSPHATE potest miscere cum ferrum. Hoc reducit corporis facultatem phosphate ferrum absorbet. Hoc ne cuiusque phosphate II horas aut saltem debet ferri accepto.

magnesium

PHOSPHATE cohaerere cum Magensio. Hoc trahunt phosphate magnesium reducit corporis vires. Hoc ne cuiusque saltem II horas ante PHOSPHATE auferri, aut a captis propioribus Magensio.

PHOSPHATE contineat cibis, et in potibus

In doctrina, taking PHOSPHATE et PHOSPHATE contineat cibis, et in potibus, ut PHOSPHATE auget periculo latus effectus in campestribus quoque et crescat, maxime in populus cum ren problems. PHOSPHATE contineat cibis includit Cola et potiones, vino, cervisia, totum frumentum cereals, nuces, dairy products et cibis ebrius.

Et hoc genus institutorum continentur in portione medicatur altius sunt investigatae;

per os:

• Phosphate humilitatis gradus ascensu nimium: Curis metiretur providers de PHOSPHATE et calcium in campestribus quoque et sanguis iustus satis ut PHOSPHATE corrigere forsit.
• Calcium enim triste caelum excelsum campester, qui sunt: Curis metiretur providers de PHOSPHATE et calcium in campestribus quoque et sanguis iustus satis ut PHOSPHATE corrigere forsit.
• Nam cum parare medical procedendi in alvum: Tres sunt quattuor tabulae praescriptione (OsmoPrep, Salix Pharma: Visicol, Salix Pharma) se continet 1.5 of P. sodium phosphate quae capta cum omnis XV minuta ad VIII uncias appendebat aquae vespere, antequam eas summa XX colonoscopy. De hoc mane, 3-4 tabellae capta cum omnis XV minuta ad VIII uncias aqua tabellae 12-20 sumpta est.
• Renibus lapides (nephrolithiasis): Kalium sales et sodium phosphate providing 1200-1500 phosphas medicamentum ex elementis sunt cotidie usus.

by IV:

• Phosphate humilitatis gradus ascensu nimium: Intravenous (IV) products PHOSPHATE vel kalium sodium phosphate quibus usi sunt. Doses 15-30 g data est mihi in 2-12 horas. Si opus fuerit, altius bibitur usi sunt.

Suspendisse victu quotidiano auxit (RDAs) de phosphate (phosphoro exprimitur) sunt filii 1-3 annorum CDLX mg 4-8 annis filii, D mg forma; viros et mulieres 9-18 annis MCCL mg forma; viros et mulieres per XVIII annos DCC medicamentum.
Adaequatum essartis (A.) ad infantes sunt, erga infantes C mg forma dosis infantibus 7-12 0-6 mensibus senis mensibus aevum et CCLXXV.
Attractio superioris gradus tolerabilis (ul) in summo gradu attractio qua expectatur effectus invitis propter phosphate (phosphoro exprimitur) diurno sunt filii 1-8 annorum diurno P. III; filii et adultis 9-70 annis, IV P. * II; adultorum maior quam LXX annis III P. * II; gravida mulieres 14-50 annis, 3.5 P. * I; et pectus-pascens mulieres 14-50 annis IV pondo. Aluminii phosphas, Bone Phosphate, calcium, calcium orthophosphate, Calcium Phosphate Dibasic Anhydrous, Calcium Phosphate-Bone Esse, Calcium Phosphate Dibasic dihydrate, Calcium Phosphate Dibasique Anhydre, Calcium Phosphate Dibasique dihydrate, Calcium Phosphate Tribasic, Calcium Phosphate Tribasique, Dibasic Calcium Phosphate dihydrate , Di-Calcium Phosphate, Dicalcium Phosphate, Dicalcium Phosphates; Neutrali Genere Quid Factum Calcium Phosphate, orthophosphate de calcium, aluminium d'PHOSPHATE, de calcium PHOSPHATE, Phosphate de magnesii, calcium PHOSPHATE de neutre, Phosphate d'O, Tricalcium PHOSPHATE, praecipitari Calcium Phosphate; Aequaliter du pHOSPHATE de calcium, precipite de pHOSPHATE de calcium, Tertiariis Calcium phosphate, Tricalcium phosphate, Whitlockite Magnesium phosphate, Merisier Potassium pHOSPHATE, Dibasic Potassium phosphate, Dipotassium Hydrogenium orthophosphate, Dipotassium monophosphate, Dipotassium phosphate, Monobasic Potassium phosphate Potassium acid phosphate ; Biphosphate Potassium Potassium dihydrogen orthophosphate Potassium Phosphate Hydrogenium, de Dipotassium Phosphate; d'Hydrogène de Potassium Phosphate, de Potassium Phosphate, de Potassium Phosphate Dibasique, Phosphate Monobasique de potassium, sodium phosphate, Anhydrous Sodium Phosphate, Dibasic Sodium Phosphate, Peroxosulphates orthophosphate Hydrogenium , Peroxosulphates Hydrogenium orthophosphate Dodecahydrate, Peroxosulphates Hydrogenium Phosphate, Peroxosulphates PHOSPHATE, Phosphate nitri, Sales de mays, Sels de Phosphate Sodium orthophosphate, orthophosphate Disodique d'Hydrogène, Phosphate Disodique d'Hydrogène, orthophosphate de sodium, de Phosphate Sodium Anhydre, Phosphate de sodium Dibasique: Aconitum napellus.

Ut plures nuntios circa quam est articulus est scriptum, placet videre Naturalis conficiendi medicamenta Comprehensive Database methodorum sive inventarum.

1. Visicol Tabulettae prescription. Populus Pharma et Raleigh, NC. Martii 2013 (https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021097s016lbl.pdf). 09/28/17 accessed.
2. Delegge M: Nabu R. efficacia apparatus per alvum in usum prepackaged, et humilis sodium victu humilis alimentorum fibra: magnesium citrate CATHARTICUM vs. manifesta liquiddiet cum vexillum sodium phosphate CATHARTICUM. Pharmacol alimentum, patris. Iun MMV XV: XXI: 1491-5. View abstracto.
3. Cicero quacdam DA, AB Barkun Cohen reclae LB, et al .; Negotium vis ad multi-US Societas Colorectal cancer. Alvus autem purgatio, pro optimizing Adequacy Colonoscopia: recommendations a multi-US Societas Negotium vis in Colorectal cancer. J am Gastroenterol MMXIV, CIX, 1528-45. View abstracto.
4. Nam SY, usores IJ Choi, KW Park, Ryu proportionales KH, HE Kim BC, Sohn DK; nam BH fefe Kim erat demonstrandum.Consociata cum periculo hemorrhagic gastropathy colonoscopy apparatus usura oris sodium phosphate alvum solvunt. Endoscopía. Feb MMX: XLII: 109-13. View abstracto.
5. Ori ego, Zvi Rosa, B, A Chagnac Joannes M, Zingerman B, E Atar, Gafter U, Korzets A. metabolicae gravibus coguntur et mortes et consociata cum usu enemas sodium phosphate, unum centrum scriptor experientia. Interne arcus Med. Feb XIII MMXII, CLXXII, 263-5. View abstracto.
6. Ladenhauf sub HN cubo Stundner Domine, Spreitzhofer F, Deluggi S.-sodium phosphate continentur asperae hyperphosphatemia administrandae iuxta alvum, apud liberos, si recensionem descriptiones systematicas et criticas seriem litterarum tempore praecesserunt. Pediatr Surg Int. Aug MMXII, XXVIII, 805-14. View abstracto.
7. Schaefer M, E Littrell: Canticum A, Patterson ME. Aestimari Gpr Ne declines Sodium Phosphate Post enemas Versus Polyethylene Glycol protegantur Colonoscopia: A Latin Retrospective cohortis Augustae. J am Herpesvirus hominis disp. Apr MMXVI, LXVII, 609-16. View abstracto.
8. Brunelli quamvis SM. Sodium phosphate alvum inter oris Association instructo paratoque profectus renibus injuriam: systematicam review et meta-analysis. J am Herpesvirus hominis disp. Mar MMIX: LIII: 448-56. View abstracto.
9. Choi NK, J Lee, ego Chang, Kim Doll, JY Kim Song HJ, Shin, JY, Jung SY, Choi ego, Cornelius Lee, Park BJ. Acuti renum defectum sodium phosphate alvus his oris adparatus nationwide, si crossover studium. Endoscopía. Iun MMXIV: XLVI: 465-70. View abstracto.
10. Belsey J: C Crosta, Domine Herpesvirus hominis, Fischbach W, Stratum P, F Parente: M. Halphen Meta-analysis: respectivae adparabat efficaciam oris alvum colonoscopy 1985-2010. Pharmacol alimentum, patris. Jan MMXII: XXXV: 222-37. View abstracto.
11. Belsey J: C Crosta, Domine Herpesvirus hominis, Fischbach W, Stratum P, F Parente: M. Halphen Meta-analysis: parva vim adhibent ad alvum endoscopy capsulae parva alvum video. Res Opin med curr. Dec MMXII, XXVIII, 1883-90. View abstracto.
12. Czuba M, Zajac A, Poprzecki S: Cholewa J: S. Woska Effectus Sodium Phosphate loading in aerobic capacitatem est fortitudo et Cyclists in off Road. J Sports Sci Med. Dec MMIX I: VIII: 591-9. View abstracto.
13. Brewer CP, Dawson B, Wallman KE, Guelfi et draconem. Sodium phosphate effectus repetita-loading super cycling iudicii tempus perficientur et VO2peak. Int J Sport Metab Nutr Exerc. Apr MMXIII: XXIII: 187-94. View abstracto.
14. Hircum CL, & KE Wallman, Dawson B, Guelfi et draconem. Sodium phosphate ergogenic ut opem. Sports Med. Iun MMXIII: XLIII: 425-35. View abstracto.
15. Hircum CL, & B Dawson, Guelfi draconem, McNaughton L. Wallman KE confecturum. Sodium phosphate, et suppletionem perficientur tempus iudicium in femina cyclists. J Sports Sci Med. Sep MMXIV I, XIII, 469-75. View abstracto.
16. Brewer CP, Dawson B, Wallman KE, Guelfi et draconem. ELOGIUM effectus De Phosphate Sodium Revolutio in I et VIII diebus Ys VO2 Post tempus Triatio, et euismod mollis tristique sem. J Sports Sci Med. Sep MMXIV I, XIII, 529-34. View abstracto.
17. Victoria Occidentem, Ay T, Wallman KE, Guelfi et draconem. Quod autem effectus in VI diebus sodium phosphate suppletionem appetitus, industria attractio, et expedivit initiatos suos, et aerobic capacitatem in mulieribus. Int J Sport Metab Nutr Exerc. Dec MMXII: XXII: 422-9. View abstracto.
18. incarnata van Pinxteren MW naciones, Kouwen MC mg van Oijen naciones, Achterberg T, Nagengast FM. Spem studio praeparatio ad alvum colonoscopy cum polyethylene glycol, electrolytici solution versus sodium phosphate Lynch apud syndrome: a randomized iudicio. FAM Cancri. Sep MMXII: XI: 337-41. View abstracto.
19. Lee SH: Canticum Lee, Kim KM, quam Auster SEO, Kang adversissimas haud XXIII, Lee tionales EH, Lee DR. Collatio de sodium phosphate salus, et virtus, et polyethylene tabulae glycol solution ad alvum purgatione Coreanica sanus adultis. Yonsei Med J. Nov MMXIV, LV, 1542-55. View abstracto.
20. Kopec BJ, Dawson B. da Vinci C, Wallman KE confecturum. Ingestion de sodium phosphate, iteratis effectus Julius, et concitus masculum athletarum facultatem. J Sci Med Virtus Scauri. Mar MMXVI: XIX: 272-6. View abstracto.
21. Jung YS, Lee CK, & Kim HJ, Eun CS Han DS Park DI. Randomized dispensata iudicio sodium phosphate de polyethylene tabulae glycol solution ad nos purgare alvum colonoscopy. J Gastroenterol mundo. MMXIV Nov XIV: XX: 15845-51. View abstracto.
22. Heaney Reverendus Recker R, P Watson, Lappe JM. PHOSPHATE et calcium carbonate diximus robust suscipio aedificium in os Osteoporosis. J am Nutr Clin. Iul MMX, XCII, 101-5. View abstracto.
23. EIL C, Fischbach W, Stratum P: Randomized M. Halphen, L. II de polyethylene dispensata iudicio versus sodium phosphate glycol plus Ascorbate components ad emundationem ante alvum ad cancer protegendo ad colonoscopy. Res Opin med curr. Dec MMXIV: XXX: 2493-503. View abstracto.
24. Hircum CL, & Henrici T, K Guelfi, Dawson B, McNaughton LR Wallman Effectus sodium phosphate J. Sprint, et certe sucus suppletionem iteratis facultatem feminas gigni. J Appl physiol. Oct MMXV; CXV, 2205-13. View abstracto.
25. Hircum C, K Guelfi, Dawson B, McNaughton Dominus: Effectus sodium phosphate, et Wallman C. Julius-loading iteratis Sprint facultatem. J Sports ed. MMXV; XXXIII, 1971-9. View abstracto.
26. Brewer CP, Dawson B, Wallman KE, Guelfi et draconem. Sodium phosphate, iteratis suppletionem effectus in altus-intensionem cycling nisus. J Sports ed. MMXV; XXXIII, 1109-16. View abstracto.
27. Folland, JP: Stern, R et Brickley, G. Sodium phosphate-loading improves iudicii tempus revolutio perficientur elit exercitatissimi sunt in cyclists. J Sci Med MMVIII Lusum, XI, 464-8. View abstracto.
28. Fisher, et JN Kitabchi, angulos eft diametro. A randomized de PHOSPHATE Lorem studium in curatio diabetic ketoacidosis. J Clin Endocrinol Metab MCMLXXXIII, LVII, 177-80. View abstracto.
29. A Terlevich: Vocem D, Woltersdorf Kessinger Publishing, et al. Refeeding syndrome: Cum curatio efficax, et tutum Phosphates Polyfusor. Ibi alimentum Pharmacol MMIII: XVII: 1325-9. View abstracto.
30. Savica, V, Calo, LA, Monardo, P, et al. Phosphoro contentus bibendi comparatum more salivati ​​et PHOSPHATE, ad effectus curatio de uremic hyperphosphatemia. J Ren Nutr MMIX, XIX, 69-72. View abstracto.
31. Hu, S, Shearer, GC Steffes, MW, Cicero, W: et Bostom, AG. Cum cotidie extenditur-phosphoro-release niacin dimittit, serum concentrationes dyslipidemia in patientibus metabolicae syndrome. Renibus Dite patre J am MMXI, LVII, 181-2. View abstracto.
32. Schaiff, RA, Haull, TG, Bar, SR. Hypercalcemia medicinae curatio est. Clin pharm MCMLXXXIX, VIII, 108-21. View abstracto.
33. Elliott, et GT McKenzie, MW. Hypercalcemia curatio est. Clin medicamento intell pharm MCMLXXXIII: XVII: 12-22. View abstracto.
34. Bugg, NC; et Jonas, JA. Hypophosphataemia. Vicipaedia: et procuratio effectus in intensive cura unitatis. Anesthesia MCMXCVIII: LIII: 895-902. View abstracto.
35. OsmoPrep prescription. Populus Pharma et Raleigh, NC. Octobris 2012. (http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021892s006lbl.pdf, accessed 02/24/15).
36. FDA sc rebus album Aprilis 2010 Available at: www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/UCM135691.pdf (accessed 2/7/15).
37. Finkelstein iecit Vivaldi, A Klibanski, Ambrosius Aurelius Theodosius AL, et al. Ne defectus estrogen-related os damnum ad humana parathyroid hormone- (1-34): a randomized dispensata iudicio. JAMA MCMXCVIII, CCLXXX, 1067-73. View abstracto.
38. Winer KK, Ko CIV, Marcus Reynolds, et al. Long-term treatment Hypoparathyreoidismus: A randomized dispensata studiis comparet parathyroid hormone (1-34) versus calcitriol et calcium. J Clin Endocrinol Metab MMIII, LXXXVIII, 4214-20. View abstracto.
39. R Lindsay vel vulgò coluntur J: C Formica, et al. Randomized dispensata studiis ad effectus hormone parathyroideae et vertebrae super os massa, Osteoporosis et fractura incidit in postmenopausal mulieres in estrogen. SCALPELLUM MCMXCVII, CCCL, 550-5. View abstracto.
40. Winer KK, Yanovski JA, cutler humana Saccharum Jr. MB 1-34 nobis calcitriol hormone parathyroideae et calcium in curatio Hypoparathyreoidismus. JAMA MCMXCVI, CCLXXVI: 631-6. View abstracto.
41. Leung in Arcanis Caelestibus, Cicero digesta est: Nomine Song: Lexicon Dobbie. Ligans in phosphas aluminium hydroxide versus sucralfate ut URAEMIA. Fr med J (Res Clin Edition) MCMLXXXIII, CCLXXXVI, 1379-81. View abstracto.
42. Roxe videlicct DM, Mistovich M, Barch DH. De Phosphate-binding sucralfate effectus in patientibus longos renum defectum. Renibus Dite patre J am MCMLXXXIX: XIII: 194-9. View abstracto.
43. Hergesell Domine, Ritz C. PHOSPHATE dolatos ex ferro est, nova perspective? Nabu renibus Suppl MCMXCIX, LXXIII, S42-5. View abstracto.
44. T Petri, L. Apuleius, Peter JF. Phosphates autem effectus in rebus humanis quam in normalis ferrum effusio iuris studiosum secundum exemplar quod per experimentum dialysis. Gastroenterology MCMLXXI: LXI: 315-22. View abstracto.
45. Monsen ER, JD Cook. Cibum ferrum effusio in rebus humanis IV. Quod effectus calcium PHOSPHATE et salibus de ferro nonheme effusio. Clin J am Nutr MCMLXXVI: XXIX: 1142-8. View abstracto.
46. R Lindsay vel vulgò coluntur J, Henneman E; et al. Amino-terminatio autem humani fragmentum parathyroideae administration of telae hormone- (1-34) equilibrium diam ac responsio per estrogenized osteoporotic aegris. J Clin Endocrinol Metab MCMXCIII, LXXVII, 1535-9. View abstracto.
47. Campisi P, V Badhwar, Morin S, J. Gauguin. Ab classe, Nitri Phospho postoperative hypocalcemic tetany praeparationem accipiens alendronate natrium patiens. Dis Colon Rectum MCMXCIX: XLII: 1499-501. View abstracto.
48. M. Safety Adham Loghman-phosphas dolatos pro novis longos renum defectum. Saf medicamento MMIII: XXVI: 1093-115. View abstracto.
49. LR Marcus Schiller, Santa Ana CA nomine Sciek MS, et al. Tempus administratione calcium et phosphoro in modum acetate binding. Best J Med MCMLXXXIX nova, CCCXX, 1110-3. View abstracto.
50. Saadeh G Bauer t Licata A L. Sheeler Antacid osteomalacia effecerunt. Clin Cleve J med MCMLXXXVII: LIV: 214-6. View abstracto.
51. Gregorius JF. Herpesvirus hominis; folate bioavailability. J Nutr MMI, CXXXI, 1376S, 1382S. View abstracto.
52. Insogna ipfarum KL, MNb Bordley proportionales Caro JF, Lockwood DH. Ingestion nimia antacid osteomalacia infirmitas. JAMA MCMLXXX, CCXLIV, 2544-6. View abstracto.
53. Heaney Reverendus Nordin BE. Calcium ad phosphoro effusio effectus, effectus pro cohibitionem Osteoporosis et co-Lorem. J AM Coll Nutr MMII: XXI: 239-44 .. View abstracto.
54. Kessinger contingentes b GH, Boullata Ji O'Rangers EA, crit et al. Intravenous curandum saturitas de PHOSPHATE et critico male aegros ad temperare hypophosphatemia. Crit Care Med MCMXCV, XXIII, 1204-10. View abstracto.
55. Perreault MM Ostrop Romae, Tierney MG. Operationes efficaciam et salutem intravenous PHOSPHATE subrogetur critico male aegros. Ann Pharmacother MCMXCVII: XXXI: 683-8. View abstracto.
56. Song: Duffy: Barthold Conlee. De PHOSPHATE loading crus effectus in potentia ANTLIA exercitium et altum intensionem. Med Sci Sports Exerc MCMLXXXVI: XVIII: 674-7. View abstracto.
57. Board cibum et nutritionem, Institute of Medicine. Reference essartis puritate alimentorum calcium, phosphoro, magnesii, Vitaminum D et Fluoride. Washington, DC: National Museum Press, 1999. Available at: http://books.nap.edu/books/0309063507/html/index.html.
58. Lucas CF acquales funt, n Lee, Woeltje erit KF •• (eds). De Graecorum Washington Medical CLINICE. 29 ad ed. New York, NY: Kessinger Publishing, Corvus et MCMXCVIII.
59. Arroyo, Alvari e aequabitur ipsi Avenozo M, T Rapado, et al. 1,25 haec inter dihydroxyvitamin serum D campester et fractas rate de intestinorum effusio de calcium in hypercalciuric nephrolithiasis. PHOSPHATE partes. Res Urol MCMXCII: XX: 96-7. View abstracto.
60. CY Heton, Lever Vicarius iudicialis Barnardum Filium Patrici BE. Osteomalacia consociata cum cholestyramine pro post-Lorem ileectomy fluxus. Gastroenterology MCMLXXII: LXII: 642-6. View abstracto.
61. Becker GL. Casus in mineralibus oleum. J am digestive dis MCMLII: XIX: 344-8. View abstracto.
62. Schwarz KB, & arcum ecliptice EN PD, Vitsaxis, s et al. Adipem-solutum Vitaminum concentratione in hypercholestrolemic filii colestipol tractata sunt. Pediatrics MCMLXXX: LXV: 243-50. View abstracto.
63. Thomas West, Ab urbe adversissimas haud XXIII. Est effectus in intestinorum effusio de cholestyramine. MCMLXXV ventrem: XVI: 93-8. View abstracto.
64. Spencer H. L. Menaham Adversa effectus aluminium-mineralis in quibus antacids metabolismi. Gastroenterology MCMLXXIX: LXXVI: 603-6. View abstracto.
65. Marcus Roberts, Knox FG. Renalis pertractatio PHOSPHATE et calcium nephrolithiasis: partes puritate alimentorum PHOSPHATE et PHOSPHATE Leak. Semin Nephrol MCMXC, X, 24-30. View abstracto.
66. Harmelin DL, Martin FR, & reparatione JD. Phosphate antacid effecerunt ut prosternerem nephrolithiasis deperditionem syndrome. Australia Aust J med MCMXC: XX: 803-5. View abstracto.
67. Gaius Rom Schlicker SA, C. procus. Essartis puritate alimentorum reference: novus enim ex calcium et suasiones related nutrimentum, vitamins B, et choline. Ego sum Dies Assoc MCMXCVIII, XCVIII, 699-706. View abstracto.
68. Fauci AS, Braunwald E, Isselbacher draconem, et al. Cicero 's Principia Internum Medicina 14th ed. New York, NY: Walter de Gruyter, MCMXCVIII.
69. Shils ME, JA Cicero, Shike M, Peter, in Arcanis Caelestibus, xii. Modern Nutrition In Salutem et Morbus. 9th ed. Recitandi, MD: bibliopolii Hahniani, MCMXCIX.
70. Gallovidia D, Tremblay MS: Sexsmith M, Roberts Cf. Quod effectus anguli PHOSPHATE suppletionem in subiectis, differentibus aerobic idoneitatem campester. J Appl physiol visset physiol MCMXCVI: LXXII: 224-30. View abstracto.
71. Helikson MA, WA Parrham virginem Tobias, dixitque JD. Hypocalcemia PHOSPHATE et hyperphosphatemia postquam hostilis in usum pueri. J Pediatr Surg MCMXCVII: XXXII: 1244-6. View abstracto.
72. DiPalma JA Inter Austrum et Eurum Buckley emendavimus: BA Warner, et al. Sodium phosphate oris diam effectis. De Dis Romanorum Sci MCMXCVI metalla fodiuntur: XLI: 749-53. View abstracto.
73. A fine, J. Patterson Gravi hyperphosphatemia PHOSPHATE haec administratio ad alvum curriculum transegeritis patientibus renum defectum, duo casibus et review de litterae. Renibus Dite patre J am MCMXCVII: XXIX: 103-5. View abstracto.
74. Clarkston WK, CA Tsen quidquam contingeret DF aequalia habeant, et al. PHOSPHATE libero, sodium oris versus sulfate apparatu colonoscopy-patiens solution in polyethylene glycol electrolytici lavage: collatio ad futurum. Gastrointest Endosc MCMXCVI: XLIII: 42-8. View abstracto.
75. Hill AG, Theo W: Adhuc A, et al. Cellular facit perspicaces ad deperditionem potassium sodium phosphate hypokalaemia iuxta oris. Aust MCMXCVIII Surg N z J: LXVIII: 856-8. View abstracto.
76. Sallust HJ, Resa, Albarran dictum est, Breslau NA, Pak CY. Reductionem in longa-term treatment sustinuit per vesica calcium PHOSPHATE et tardus remissionis, in neutrum kalium absorptive hypercalciuria. J Urol MCMXCVIII, CLIX, 1451-5; 1455-6 disputationem. View abstracto.
77. C. HARDMAN, LL Limbird: HB Molinoff, Eds. Pharmacological et familias ac Gillman est Basis autem Therapeutics, 9th ed. New York, NY: Walter de Gruyter, MCMXCVI.
78. Young VIII. Laboratorium expertus Medicamenta in effectis, Volume 4 ed. Washington: AACC Press, MCMXCV.
79. McEvoy William, ed. AHFS medicamentis Information. Bethesda, MD: Salutem ex-American Societas Ratio pharmacopolarum MCMXCVIII.
80. Bibliotheca medicinae ex herba medicinae usu. Exoniae UK: De Europae Co-op Phytother, MCMXCVII.

From Review - 01/29/2019